Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07315945

Implementation of an Allergic Rhinitis Severity Questionnaire in ENT Consultations

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Allergic rhinitis is a very common condition (affecting 1 in 5 people in Europe) and a costly one for society (direct and indirect costs). Symptoms vary depending on the time of year, and treatments are primarily symptomatic, with follow-up in ENT consultations. Scientific societies (EAACI, FDA, EMA) recommend using a universal tool (severity score) (the CSMS score, SCST in French) to monitor severity and follow-up, and to obtain consistent data that can be extrapolated to other scientific data (meta-analyses). Therefore, investigators in the ENT department use this SCST score (as well as others such as the SNOT 22 score) to assess the severity of allergic rhinitis in our patients and its progression. Tbe investigators wish to confirm the acceptability of this tool for patients, and the statistical value of its properties.

Conditions

Timeline

Start date
2025-06-10
Primary completion
2026-02-01
Completion
2026-02-01
First posted
2026-01-05
Last updated
2026-01-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07315945. Inclusion in this directory is not an endorsement.

Implementation of an Allergic Rhinitis Severity Questionnaire in ENT Consultations (NCT07315945) · Clinical Trials Directory